Search the Newsreel

BEAT: FDA pre-submission for heart attack detection and commercial rollout drive growth, with costs down

Heartbeam, Inc. (BEAT) is advancing its heart attack detection initiatives, having submitted to the FDA and rapidly enrolled clinical participants. The company saw a decrease in operating cash outflows and net loss, and extended its cash runway into 2027, driven by a successful commercial …

HeartBeam Q2 Results: Net loss narrows to $5M, cash burn down 7%

HeartBeam Inc. reported a Q2 2026 net loss of $5 million, with its operating cash outflow decreasing by 7% quarter-over-quarter to $3.3 million. The company's cash and equivalents stood at $8.8 million, with a projected cash runway into 2027. HeartBeam is progressing with FDA …

Earnings call transcript: HeartBeam posts wider Q2 2026 loss, stock slips after hours

HeartBeam Inc. reported a wider-than-expected Q2 2026 loss of -$1.10 per share, significantly missing analyst estimates, causing its stock to slip after hours despite initial gains. The company highlighted progress in reducing operating cash burn, launching its HeartBeam card, and advancing clinical development for …

HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates

HeartFlow (HTFL) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $1.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

Why is Heartbeam stock sliding today?

Heartbeam Inc. (BEAT) stock slid 1.7% in after-hours trading after the company reported a wider-than-expected net loss of $0.10 per share for Q2 2026, missing analyst estimates. Despite lowering its full-year cash outflow guidance and completing enrollment for a key clinical study ahead of …

HeartBeam, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BEAT) 2026-08-13

Wellington Management reports 9.12% Heartflow (HTFL) stake in Schedule 13G/A

Wellington Management Group LLP and its related entities have filed an amended Schedule 13G (Amendment No. 3) for Heartflow, Inc. (HTFL), reporting a beneficial ownership of 9.12% of the common stock, totaling 7,864,226 shares as of June 30, 2026. The filing indicates shared voting …

Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Heartflow, a leader in AI technology for diagnosing coronary artery disease, reported strong financial results for the second quarter of 2026, with total revenue increasing by 48% year-over-year to $64.1 million. The company also raised its full-year 2026 revenue guidance to between $246 million …

Heartflow posts Q2 2026 revenue $64.1M, raises 2026 revenue outlook to $246–250M

Heartflow reported strong second-quarter 2026 results with total revenue of $64.1 million, a 48% year-over-year increase, and significantly narrowed its non-GAAP net operating loss. The company achieved a record gross margin of 83.0% and raised its full-year 2026 revenue guidance to $246 million–$250 million. …

Heartflow soars 15% on earnings beat, raised guidance

Heartflow Inc. (NASDAQ:HTFL) reported strong second-quarter results, exceeding analyst expectations with an adjusted loss per share of -$0.07 and revenue of $64.1 million. The company also raised its full-year 2026 revenue guidance to $246 million-$250 million, leading to a 15% surge in after-hours trading. …

Deutsche Bank AG (IHRT) reports 4.9% beneficial stake in iHeartMedia in 13G/A

Deutsche Bank AG has reported a beneficial ownership of 4.9% in iHeartMedia, Inc.'s Class A common stock, totaling 6,342,011 shares. This stake, disclosed in a Schedule 13G/A filing, is held with shared voting and dispositive power, falling just below the 5% threshold that would …

HeartBeam (NASDAQ: BEAT) details Q2 loss, $11.5M equity raise and Nasdaq risk

HeartBeam Reports Second Quarter 2026 Results

HeartBeam, Inc. announced its financial and operational results for the second quarter ended June 30, 2026, highlighting significant advancements in heart attack detection clinical studies, including ahead-of-schedule enrollment in ALIGN-ACS and HEADSTART-ACS pilot studies. The company also reported progress on its initial commercial launch …

Form 8K HEARTCORE ENTERPRISES For: 13 August By Investing.com

This article announces that HEARTCORE ENTERPRISES filed a Form 8K on August 13. The brief notice from Investing.com includes the stock symbol HTCR, which showed a gain of 6.07%. No further details about the content of the 8K filing are provided.

Lionheart Holdings (NYSE: CUB) sees 6.52% stake reported by Decagon Asset Management

Decagon Asset Management LLP and Benjamin John Durham have reported a beneficial ownership of 1,500,000 Class A ordinary shares in Lionheart Holdings (NYSE: CUB), which constitutes a 6.52% stake in the company. Both parties maintain sole voting and dispositive power over these shares, with …

HeartCore Enterprises earnings missed by $1.85, revenue fell short of estimates

HeartCore Enterprises (NASDAQ: HTCR) reported second-quarter earnings per share of $-1.4500, significantly missing the analyst estimate of $0.4000 by $1.85. The company's revenue for the quarter also fell short, coming in at $321K against a consensus estimate of $6.2M. Following these results, the stock …

AQR group discloses 1.4M Lionheart Holdings shares in 13G/A filing (CUB)

AQR Capital Management, LLC, along with AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC, has disclosed an amended beneficial ownership of 1,400,000 Class A ordinary shares in Lionheart Holdings (CUB), representing 6.51% of the outstanding class. The entities hold shared voting and dispositive …

HeartFlow: Q2 Earnings Snapshot

HeartFlow Inc. (HTFL) reported a Q2 loss of $15.7 million, or 18 cents per share, which adjusted to 7 cents per share, beating analyst expectations. The medical technology company also surpassed revenue forecasts with $64.1 million for the period and projects full-year revenue between …

Heartflow earnings up next: Can Plaque Analysis sustain growth?

Heartflow Inc. is set to report second-quarter earnings, with analysts anticipating a loss of $0.19 per share, though year-over-year losses are narrowing significantly. Investors will be closely watching the adoption rates of its Plaque Analysis, the sustainability of its revenue growth, and its path …

HeartCore Swings to $2M Q2 Net Loss on $321K Revenue

HeartCore (Nasdaq: HTCR) reported a Q2 2026 revenue of $321,000, a 71.6% increase year-over-year, primarily due to higher software development services. However, the company swung to a net loss of $2.0 million from a net income of $1.1 million in the prior year, with …

HeartCore reports Q2 2026: Revenues $321K, Net loss $2.0M, Adjusted EBITDA $(1.3)M

HeartCore reported its Q2 2026 results, showing revenues of $321,000, a net loss of $2.0 million, and an Adjusted EBITDA loss of $1.3 million. The company is undergoing portfolio simplification, including the divestiture of Sigmaways and the planned sale of its interest in HeartCore …

HeartCore Reports Second Quarter 2026 Financial Results

HeartCore Enterprises, Inc. reported its second quarter 2026 financial results, highlighting a strategic shift towards its core Go IPO consulting business through the divestiture of Sigmaways and the pending sale of its stake in HeartCore Luvina Vietnam. While revenues increased by 71.6% in Q2 …

HeartCore Enterprises, Inc. Q2 2026: Revenue $321428 EPS $(1.45) — 10-Q Summary

HeartCore Enterprises, Inc. reported its Q2 2026 results, with revenue increasing to $321,428, up 71.6% year-over-year, primarily due to higher software development orders. Despite revenue growth, the company swung to a net loss of $2,042,436 and a diluted EPS of $(1.45). HeartCore has completed …

HeartCore Q2 Revenue Rises 72% to $321,000 as Net Loss Reaches $2.0 Million

HeartCore (HTCR) reported a significant revenue increase of 71.6% to $321,000 in Q2 2026, compared to the previous year, but also recorded a net loss of $2.0 million, a decline from the prior year's net income. For the first half of 2026, the company's …

HeartCore Enterprises (NASDAQ: HTCR) logs $4,016,234 loss and raises going concern doubts

HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript

HeartBeam Inc. (NASDAQ: BEAT) reported a 7% decrease in operating cash outflow for Q2 2026, focusing on cost management and efficiency. The company submitted a pre-submission to the FDA for heart attack detection, with clinical trials expected by year-end, and is gaining momentum with …

Heartflow CEO John Farquhar sells $638,730 in common stock

Heartflow CEO John C.M. Farquhar sold 22,562 shares of the company's common stock for approximately $638,730. This transaction was executed under a Rule 10b5-1 trading plan. The company recently reported strong Q1 2026 earnings, exceeding analyst expectations, and has received positive ratings from several …

Heartland Express, Inc. (HTLD) Stock Forecasts

Argus has lowered its target price for Heartland Express Inc. (HTLD) to $12.00, citing the company's engagement in truckload services across North America. The current stock price for HTLD is $12.68. The report recommends upgrading for premium research and detailed company insights.

Heartland Express Inc (HTLD) Shares Surge 4.2% -- What GF Score of 66 Tells Investors

Heartland Express Inc (HTLD) shares surged 4.2% despite a 17.0% decline over the past month, yet GuruFocus assesses the stock as significantly overvalued with a GF Value of $7.89 against a current price of $12.29. The company's GF Score of 66/100, driven by strong …

Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 22,562 Shares

Heartflow CEO John C.M. Farquhar sold 22,562 shares of the company's stock for over $638,000, reducing his direct holdings by 4.92%. This transaction was made under a pre-arranged Rule 10b5-1 trading plan. Despite the insider sale, Heartflow's stock rose 1.0%, and the company exceeded …

Lionheart Holdings Class A Ordinary Shares (NASDAQ:CUB) Short Interest Up 610.8% in July

Lionheart Holdings Class A Ordinary Shares (NASDAQ:CUB) experienced a significant surge in short interest in July, increasing by 610.8% to 18,268 shares, although this represents only about 0.1% of its total shares. Analyst sentiment for CUB remains negative, with a consensus "Sell" rating, despite …

HeartFlow Inc (HTFL) Q2 2026 Earnings Report Preview: What To Expect

Greenheart Group Sets August Board Meeting to Approve Interim Results

Quantinno Capital Management LP Acquires Shares of 71,271 Heartflow, Inc. $HTFL

Quantinno Capital Management LP has acquired 71,271 shares of Heartflow, Inc. (NASDAQ:HTFL), valued at approximately $1.734 million, representing a 0.08% stake. This move comes as other institutional investors have also initiated positions, and analysts maintain a "Moderate Buy" rating for Heartflow with an average …

Lionheart Holdings (CUB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Greenheart Group Limited Revenue Breakdown – HKEX:94